P21 is a neurogenic peptide derived from CNTF that has generated significant interest in neurodegenerative disease research. Its ability to promote new neuron formation in the adult hippocampus makes it relevant to both cognitive enhancement and disease modification research.
Research Applications
Hippocampal neurogenesis, Alzheimer’s disease models, cognitive enhancement, BDNF pathway research, and neural stem cell biology.
Dosage Information (Research Use)
Animal research: 60-750 nmol/g intranasally or peripherally. Research use only.
Reconstitution & Handling
Standard BAC water reconstitution.
Half-Life & Pharmacokinetics
Not well characterized. Intranasal route preferred for CNS delivery.
Reported Observations in Literature
Limited data. Generally well-tolerated in animal models.
Key Research References
- Bolognin D, et al. “An experimental rat model of sporadic Alzheimer’s disease and rescue of cognitive impairment with a neurotrophic peptide.” Acta Neuropathol. 2012